nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Cytochrome P450 2C19 Inhibitors—Topiramate—epilepsy syndrome	0.516	1	CiPCiCtD
Esomeprazole—CYP2C19—epilepsy syndrome	0.12	1	CbGaD
Esomeprazole—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0156	0.0692	CbGbCtD
Esomeprazole—CYP2C19—Felbamate—epilepsy syndrome	0.0145	0.0643	CbGbCtD
Esomeprazole—CYP2C19—Trimethadione—epilepsy syndrome	0.0145	0.0643	CbGbCtD
Esomeprazole—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0137	0.0605	CbGbCtD
Esomeprazole—CYP2C19—Clobazam—epilepsy syndrome	0.0118	0.0524	CbGbCtD
Esomeprazole—CYP2C19—Carbamazepine—epilepsy syndrome	0.00981	0.0435	CbGbCtD
Esomeprazole—CYP2C19—Primidone—epilepsy syndrome	0.00916	0.0406	CbGbCtD
Esomeprazole—CYP2C19—Phenytoin—epilepsy syndrome	0.0088	0.039	CbGbCtD
Esomeprazole—CYP2C19—Propofol—epilepsy syndrome	0.00821	0.0364	CbGbCtD
Esomeprazole—CYP2C19—Phenobarbital—epilepsy syndrome	0.00784	0.0347	CbGbCtD
Esomeprazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00755	0.0335	CbGbCtD
Esomeprazole—CYP2C19—Diazepam—epilepsy syndrome	0.00744	0.0329	CbGbCtD
Esomeprazole—CYP2C19—Zonisamide—epilepsy syndrome	0.00726	0.0321	CbGbCtD
Esomeprazole—CYP3A4—Felbamate—epilepsy syndrome	0.00702	0.0311	CbGbCtD
Esomeprazole—CYP3A4—Trimethadione—epilepsy syndrome	0.00702	0.0311	CbGbCtD
Esomeprazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0066	0.0292	CbGbCtD
Esomeprazole—CYP3A4—Clonazepam—epilepsy syndrome	0.00597	0.0264	CbGbCtD
Esomeprazole—CYP2C19—Valproic Acid—epilepsy syndrome	0.00586	0.026	CbGbCtD
Esomeprazole—CYP3A4—Clobazam—epilepsy syndrome	0.00572	0.0254	CbGbCtD
Esomeprazole—CYP2C19—Topiramate—epilepsy syndrome	0.00529	0.0234	CbGbCtD
Esomeprazole—CYP3A4—Rufinamide—epilepsy syndrome	0.00487	0.0216	CbGbCtD
Esomeprazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00474	0.021	CbGbCtD
Esomeprazole—CYP3A4—Primidone—epilepsy syndrome	0.00443	0.0196	CbGbCtD
Esomeprazole—CYP3A4—Phenytoin—epilepsy syndrome	0.00425	0.0188	CbGbCtD
Esomeprazole—CYP3A4—Propofol—epilepsy syndrome	0.00397	0.0176	CbGbCtD
Esomeprazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00379	0.0168	CbGbCtD
Esomeprazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00379	0.0168	CbGbCtD
Esomeprazole—CYP3A4—Midazolam—epilepsy syndrome	0.00374	0.0166	CbGbCtD
Esomeprazole—CYP3A4—Diazepam—epilepsy syndrome	0.00359	0.0159	CbGbCtD
Esomeprazole—CYP3A4—Zonisamide—epilepsy syndrome	0.00351	0.0155	CbGbCtD
Esomeprazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00283	0.0126	CbGbCtD
Esomeprazole—CYP3A4—Topiramate—epilepsy syndrome	0.00256	0.0113	CbGbCtD
Esomeprazole—Omeprazole—CYP11A1—epilepsy syndrome	0.000321	0.158	CrCbGaD
Esomeprazole—Rabeprazole—ABCG2—epilepsy syndrome	0.000192	0.0944	CrCbGaD
Esomeprazole—Pantoprazole—ABCG2—epilepsy syndrome	0.000192	0.0944	CrCbGaD
Esomeprazole—Omeprazole—ABCG2—epilepsy syndrome	0.000156	0.077	CrCbGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000154	0.00613	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000152	0.00604	CbGpPWpGaD
Esomeprazole—Rabeprazole—CYP2C19—epilepsy syndrome	0.000151	0.0742	CrCbGaD
Esomeprazole—Pantoprazole—CYP2C19—epilepsy syndrome	0.000151	0.0742	CrCbGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000144	0.00573	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000144	0.00573	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000144	0.00573	CbGpPWpGaD
Esomeprazole—Lansoprazole—ABCG2—epilepsy syndrome	0.000143	0.0704	CrCbGaD
Esomeprazole—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000139	0.00554	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000137	0.00546	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000137	0.00546	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000126	0.005	CbGpPWpGaD
Esomeprazole—Omeprazole—CYP2C19—epilepsy syndrome	0.000123	0.0605	CrCbGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000122	0.00487	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000122	0.00487	CbGpPWpGaD
Esomeprazole—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00012	0.00477	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000117	0.00465	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000116	0.00462	CbGpPWpGaD
Esomeprazole—Lansoprazole—CYP2C19—epilepsy syndrome	0.000112	0.0553	CrCbGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000112	0.00445	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000112	0.00445	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000112	0.00445	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000112	0.00445	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000112	0.00445	CbGpPWpGaD
Esomeprazole—Rabeprazole—CYP2D6—epilepsy syndrome	0.000112	0.055	CrCbGaD
Esomeprazole—CYP2C19—Xenobiotics—CYP2D6—epilepsy syndrome	0.000111	0.00443	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000109	0.00434	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000109	0.00434	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000107	0.00426	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000104	0.00414	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000104	0.00414	CbGpPWpGaD
Esomeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000103	0.00409	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000103	0.00408	CbGpPWpGaD
Esomeprazole—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000102	0.00405	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	9.98e-05	0.00397	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	9.98e-05	0.00397	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	9.98e-05	0.00397	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	9.98e-05	0.00397	CbGpPWpGaD
Esomeprazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	9.95e-05	0.00396	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	9.93e-05	0.00395	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	9.79e-05	0.00389	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	9.52e-05	0.00379	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	9.28e-05	0.00369	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	9.17e-05	0.00365	CbGpPWpGaD
Esomeprazole—Omeprazole—CYP2D6—epilepsy syndrome	9.1e-05	0.0449	CrCbGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	8.85e-05	0.00352	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	8.85e-05	0.00352	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	8.85e-05	0.00352	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	8.73e-05	0.00347	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	8.49e-05	0.00338	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	8.49e-05	0.00338	CbGpPWpGaD
Esomeprazole—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	8.44e-05	0.00336	CbGpPWpGaD
Esomeprazole—Lansoprazole—CYP2D6—epilepsy syndrome	8.32e-05	0.041	CrCbGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	8.27e-05	0.00329	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	8.17e-05	0.00325	CbGpPWpGaD
Esomeprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	8e-05	0.00318	CbGpPWpGaD
Esomeprazole—Pantoprazole—ABCB1—epilepsy syndrome	7.97e-05	0.0393	CrCbGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	7.89e-05	0.00314	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	7.89e-05	0.00314	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	7.89e-05	0.00314	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	7.57e-05	0.00301	CbGpPWpGaD
Esomeprazole—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	7.46e-05	0.00297	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	7.22e-05	0.00287	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	7.18e-05	0.00285	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	7.03e-05	0.0028	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	7.03e-05	0.0028	CbGpPWpGaD
Esomeprazole—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	6.69e-05	0.00266	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—KCNAB2—epilepsy syndrome	6.64e-05	0.00264	CbGpPWpGaD
Esomeprazole—Omeprazole—ABCB1—epilepsy syndrome	6.5e-05	0.032	CrCbGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	6.44e-05	0.00256	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.43e-05	0.00256	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	6.27e-05	0.00249	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	6.19e-05	0.00246	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.98e-05	0.00238	CbGpPWpGaD
Esomeprazole—Lansoprazole—ABCB1—epilepsy syndrome	5.94e-05	0.0293	CrCbGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	5.89e-05	0.00234	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.7e-05	0.00227	CbGpPWpGaD
Esomeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	5.46e-05	0.00217	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	5.44e-05	0.00216	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	5.43e-05	0.00216	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	5.41e-05	0.00215	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.33e-05	0.00212	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	5.12e-05	0.00204	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	5.12e-05	0.00204	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.08e-05	0.00202	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	5.06e-05	0.00201	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—APOE—epilepsy syndrome	4.72e-05	0.00188	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.69e-05	0.00187	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.65e-05	0.00185	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	4.62e-05	0.00184	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	4.56e-05	0.00181	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.5e-05	0.00179	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.18e-05	0.00166	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	4.15e-05	0.00165	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.15e-05	0.00165	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.01e-05	0.0016	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	3.99e-05	0.00159	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.75e-05	0.00149	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—GPX1—epilepsy syndrome	3.55e-05	0.00141	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	3.28e-05	0.00131	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.13e-05	0.00124	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.12e-05	0.00124	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.1e-05	0.00123	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.08e-05	0.00123	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.06e-05	0.00122	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.04e-05	0.00121	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.82e-05	0.00112	CbGpPWpGaD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	2.78e-05	0.00111	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	2.74e-05	0.00109	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	2.58e-05	0.00103	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	2.58e-05	0.00103	CbGpPWpGaD
Esomeprazole—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	2.52e-05	0.001	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.51e-05	0.000999	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.51e-05	0.000999	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.5e-05	0.000993	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.26e-05	0.000901	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.25e-05	0.000896	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP11A1—epilepsy syndrome	2.21e-05	0.000877	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.18e-05	0.000865	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.09e-05	0.000831	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP2D6—epilepsy syndrome	1.99e-05	0.000792	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.96e-05	0.000781	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	1.96e-05	0.000779	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.84e-05	0.00073	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	1.79e-05	0.000712	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.72e-05	0.000686	CbGpPWpGaD
Esomeprazole—Anorexia—Valproic Acid—epilepsy syndrome	1.72e-05	0.000155	CcSEcCtD
Esomeprazole—Tremor—Gabapentin—epilepsy syndrome	1.72e-05	0.000155	CcSEcCtD
Esomeprazole—Rash—Diazepam—epilepsy syndrome	1.71e-05	0.000154	CcSEcCtD
Esomeprazole—Dermatitis—Diazepam—epilepsy syndrome	1.71e-05	0.000154	CcSEcCtD
Esomeprazole—Visual impairment—Topiramate—epilepsy syndrome	1.71e-05	0.000154	CcSEcCtD
Esomeprazole—Arthralgia—Pregabalin—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Myalgia—Pregabalin—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Chest pain—Pregabalin—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Dizziness—Zonisamide—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Headache—Diazepam—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Anxiety—Pregabalin—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Diarrhoea—Clonazepam—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Anaemia—Gabapentin—epilepsy syndrome	1.7e-05	0.000153	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.69e-05	0.000152	CcSEcCtD
Esomeprazole—Asthenia—Carbamazepine—epilepsy syndrome	1.69e-05	0.000152	CcSEcCtD
Esomeprazole—Agitation—Gabapentin—epilepsy syndrome	1.69e-05	0.000152	CcSEcCtD
Esomeprazole—Diarrhoea—Phenytoin—epilepsy syndrome	1.69e-05	0.000152	CcSEcCtD
Esomeprazole—Discomfort—Pregabalin—epilepsy syndrome	1.68e-05	0.000152	CcSEcCtD
Esomeprazole—Nausea—Fosphenytoin—epilepsy syndrome	1.68e-05	0.000151	CcSEcCtD
Esomeprazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.68e-05	0.000151	CcSEcCtD
Esomeprazole—Erythema multiforme—Topiramate—epilepsy syndrome	1.68e-05	0.000151	CcSEcCtD
Esomeprazole—Angioedema—Gabapentin—epilepsy syndrome	1.68e-05	0.000151	CcSEcCtD
Esomeprazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.67e-05	0.000151	CcSEcCtD
Esomeprazole—Vomiting—Felbamate—epilepsy syndrome	1.67e-05	0.000151	CcSEcCtD
Esomeprazole—Dry mouth—Pregabalin—epilepsy syndrome	1.67e-05	0.00015	CcSEcCtD
Esomeprazole—Pruritus—Carbamazepine—epilepsy syndrome	1.66e-05	0.00015	CcSEcCtD
Esomeprazole—Rash—Felbamate—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Esomeprazole—Eye disorder—Topiramate—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Esomeprazole—Dermatitis—Felbamate—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Esomeprazole—Malaise—Gabapentin—epilepsy syndrome	1.65e-05	0.000149	CcSEcCtD
Esomeprazole—Tinnitus—Topiramate—epilepsy syndrome	1.65e-05	0.000149	CcSEcCtD
Esomeprazole—Vertigo—Gabapentin—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Esomeprazole—Headache—Felbamate—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Esomeprazole—Confusional state—Pregabalin—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Esomeprazole—Flushing—Topiramate—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Esomeprazole—Leukopenia—Gabapentin—epilepsy syndrome	1.64e-05	0.000148	CcSEcCtD
Esomeprazole—Dizziness—Clonazepam—epilepsy syndrome	1.64e-05	0.000148	CcSEcCtD
Esomeprazole—Nausea—Vigabatrin—epilepsy syndrome	1.64e-05	0.000148	CcSEcCtD
Esomeprazole—Vomiting—Zonisamide—epilepsy syndrome	1.64e-05	0.000147	CcSEcCtD
Esomeprazole—Insomnia—Valproic Acid—epilepsy syndrome	1.63e-05	0.000147	CcSEcCtD
Esomeprazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.63e-05	0.000147	CcSEcCtD
Esomeprazole—Asthenia—Lamotrigine—epilepsy syndrome	1.63e-05	0.000147	CcSEcCtD
Esomeprazole—Dizziness—Phenytoin—epilepsy syndrome	1.63e-05	0.000147	CcSEcCtD
Esomeprazole—Rash—Zonisamide—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Esomeprazole—Infection—Pregabalin—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Esomeprazole—Paraesthesia—Valproic Acid—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Esomeprazole—Palpitations—Gabapentin—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Esomeprazole—Dermatitis—Zonisamide—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Esomeprazole—Dizziness—Oxcarbazepine—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Esomeprazole—Nausea—Diazepam—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Headache—Zonisamide—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Dyspnoea—Valproic Acid—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Diarrhoea—Carbamazepine—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Pruritus—Lamotrigine—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Shock—Pregabalin—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Somnolence—Valproic Acid—epilepsy syndrome	1.61e-05	0.000145	CcSEcCtD
Esomeprazole—Immune system disorder—Topiramate—epilepsy syndrome	1.6e-05	0.000144	CcSEcCtD
Esomeprazole—Nervous system disorder—Pregabalin—epilepsy syndrome	1.6e-05	0.000144	CcSEcCtD
Esomeprazole—Cough—Gabapentin—epilepsy syndrome	1.6e-05	0.000144	CcSEcCtD
Esomeprazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.6e-05	0.000144	CcSEcCtD
Esomeprazole—Mediastinal disorder—Topiramate—epilepsy syndrome	1.6e-05	0.000144	CcSEcCtD
Esomeprazole—Tachycardia—Pregabalin—epilepsy syndrome	1.59e-05	0.000144	CcSEcCtD
Esomeprazole—Chills—Topiramate—epilepsy syndrome	1.59e-05	0.000143	CcSEcCtD
Esomeprazole—Dyspepsia—Valproic Acid—epilepsy syndrome	1.59e-05	0.000143	CcSEcCtD
Esomeprazole—Skin disorder—Pregabalin—epilepsy syndrome	1.59e-05	0.000143	CcSEcCtD
Esomeprazole—Hypertension—Gabapentin—epilepsy syndrome	1.58e-05	0.000143	CcSEcCtD
Esomeprazole—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.58e-05	0.000142	CcSEcCtD
Esomeprazole—Vomiting—Clonazepam—epilepsy syndrome	1.58e-05	0.000142	CcSEcCtD
Esomeprazole—Decreased appetite—Valproic Acid—epilepsy syndrome	1.57e-05	0.000141	CcSEcCtD
Esomeprazole—Alopecia—Topiramate—epilepsy syndrome	1.57e-05	0.000141	CcSEcCtD
Esomeprazole—Vomiting—Phenytoin—epilepsy syndrome	1.57e-05	0.000141	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.57e-05	0.000623	CbGpPWpGaD
Esomeprazole—Rash—Clonazepam—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Esomeprazole—Dermatitis—Clonazepam—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Esomeprazole—Arthralgia—Gabapentin—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Esomeprazole—Myalgia—Gabapentin—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Esomeprazole—Chest pain—Gabapentin—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Esomeprazole—Nausea—Felbamate—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Vomiting—Oxcarbazepine—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Fatigue—Valproic Acid—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Anxiety—Gabapentin—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Anorexia—Pregabalin—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Dizziness—Carbamazepine—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Diarrhoea—Lamotrigine—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Esomeprazole—Headache—Clonazepam—epilepsy syndrome	1.55e-05	0.00014	CcSEcCtD
Esomeprazole—Rash—Phenytoin—epilepsy syndrome	1.55e-05	0.00014	CcSEcCtD
Esomeprazole—Mental disorder—Topiramate—epilepsy syndrome	1.55e-05	0.00014	CcSEcCtD
Esomeprazole—Dermatitis—Phenytoin—epilepsy syndrome	1.55e-05	0.00014	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.55e-05	0.00014	CcSEcCtD
Esomeprazole—Rash—Oxcarbazepine—epilepsy syndrome	1.55e-05	0.000139	CcSEcCtD
Esomeprazole—Pain—Valproic Acid—epilepsy syndrome	1.54e-05	0.000139	CcSEcCtD
Esomeprazole—Constipation—Valproic Acid—epilepsy syndrome	1.54e-05	0.000139	CcSEcCtD
Esomeprazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.54e-05	0.000139	CcSEcCtD
Esomeprazole—Headache—Phenytoin—epilepsy syndrome	1.54e-05	0.000139	CcSEcCtD
Esomeprazole—Malnutrition—Topiramate—epilepsy syndrome	1.54e-05	0.000139	CcSEcCtD
Esomeprazole—Discomfort—Gabapentin—epilepsy syndrome	1.54e-05	0.000139	CcSEcCtD
Esomeprazole—Headache—Oxcarbazepine—epilepsy syndrome	1.54e-05	0.000138	CcSEcCtD
Esomeprazole—Nausea—Zonisamide—epilepsy syndrome	1.53e-05	0.000138	CcSEcCtD
Esomeprazole—Dry mouth—Gabapentin—epilepsy syndrome	1.53e-05	0.000138	CcSEcCtD
Esomeprazole—Flatulence—Topiramate—epilepsy syndrome	1.52e-05	0.000137	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CA13—epilepsy syndrome	1.52e-05	0.000604	CbGpPWpGaD
Esomeprazole—Tension—Topiramate—epilepsy syndrome	1.51e-05	0.000136	CcSEcCtD
Esomeprazole—Dysgeusia—Topiramate—epilepsy syndrome	1.51e-05	0.000136	CcSEcCtD
Esomeprazole—Confusional state—Gabapentin—epilepsy syndrome	1.51e-05	0.000136	CcSEcCtD
Esomeprazole—Dizziness—Lamotrigine—epilepsy syndrome	1.5e-05	0.000135	CcSEcCtD
Esomeprazole—Nervousness—Topiramate—epilepsy syndrome	1.5e-05	0.000135	CcSEcCtD
Esomeprazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.5e-05	0.000135	CcSEcCtD
Esomeprazole—Vomiting—Carbamazepine—epilepsy syndrome	1.5e-05	0.000135	CcSEcCtD
Esomeprazole—Back pain—Topiramate—epilepsy syndrome	1.49e-05	0.000134	CcSEcCtD
Esomeprazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.49e-05	0.000134	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.49e-05	0.000134	CcSEcCtD
Esomeprazole—Infection—Gabapentin—epilepsy syndrome	1.49e-05	0.000134	CcSEcCtD
Esomeprazole—Muscle spasms—Topiramate—epilepsy syndrome	1.48e-05	0.000134	CcSEcCtD
Esomeprazole—Rash—Carbamazepine—epilepsy syndrome	1.48e-05	0.000134	CcSEcCtD
Esomeprazole—Dermatitis—Carbamazepine—epilepsy syndrome	1.48e-05	0.000133	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.48e-05	0.000133	CcSEcCtD
Esomeprazole—Insomnia—Pregabalin—epilepsy syndrome	1.48e-05	0.000133	CcSEcCtD
Esomeprazole—Nausea—Clonazepam—epilepsy syndrome	1.47e-05	0.000133	CcSEcCtD
Esomeprazole—Headache—Carbamazepine—epilepsy syndrome	1.47e-05	0.000133	CcSEcCtD
Esomeprazole—Shock—Gabapentin—epilepsy syndrome	1.47e-05	0.000133	CcSEcCtD
Esomeprazole—Nervous system disorder—Gabapentin—epilepsy syndrome	1.47e-05	0.000132	CcSEcCtD
Esomeprazole—Paraesthesia—Pregabalin—epilepsy syndrome	1.47e-05	0.000132	CcSEcCtD
Esomeprazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.47e-05	0.000132	CcSEcCtD
Esomeprazole—Nausea—Phenytoin—epilepsy syndrome	1.46e-05	0.000132	CcSEcCtD
Esomeprazole—Tachycardia—Gabapentin—epilepsy syndrome	1.46e-05	0.000132	CcSEcCtD
Esomeprazole—Dyspnoea—Pregabalin—epilepsy syndrome	1.46e-05	0.000131	CcSEcCtD
Esomeprazole—Nausea—Oxcarbazepine—epilepsy syndrome	1.46e-05	0.000131	CcSEcCtD
Esomeprazole—Vision blurred—Topiramate—epilepsy syndrome	1.45e-05	0.000131	CcSEcCtD
Esomeprazole—Skin disorder—Gabapentin—epilepsy syndrome	1.45e-05	0.000131	CcSEcCtD
Esomeprazole—Somnolence—Pregabalin—epilepsy syndrome	1.45e-05	0.000131	CcSEcCtD
Esomeprazole—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Esomeprazole—Tremor—Topiramate—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Esomeprazole—Vomiting—Lamotrigine—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Esomeprazole—Urticaria—Valproic Acid—epilepsy syndrome	1.44e-05	0.000129	CcSEcCtD
Esomeprazole—Rash—Lamotrigine—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Ill-defined disorder—Topiramate—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Dermatitis—Lamotrigine—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Body temperature increased—Valproic Acid—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Abdominal pain—Valproic Acid—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Anorexia—Gabapentin—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Anaemia—Topiramate—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Esomeprazole—Headache—Lamotrigine—epilepsy syndrome	1.42e-05	0.000128	CcSEcCtD
Esomeprazole—Decreased appetite—Pregabalin—epilepsy syndrome	1.42e-05	0.000128	CcSEcCtD
Esomeprazole—Agitation—Topiramate—epilepsy syndrome	1.42e-05	0.000128	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.41e-05	0.000127	CcSEcCtD
Esomeprazole—Fatigue—Pregabalin—epilepsy syndrome	1.41e-05	0.000127	CcSEcCtD
Esomeprazole—Nausea—Carbamazepine—epilepsy syndrome	1.4e-05	0.000126	CcSEcCtD
Esomeprazole—Pain—Pregabalin—epilepsy syndrome	1.4e-05	0.000126	CcSEcCtD
Esomeprazole—Constipation—Pregabalin—epilepsy syndrome	1.4e-05	0.000126	CcSEcCtD
Esomeprazole—Malaise—Topiramate—epilepsy syndrome	1.39e-05	0.000125	CcSEcCtD
Esomeprazole—Vertigo—Topiramate—epilepsy syndrome	1.39e-05	0.000125	CcSEcCtD
Esomeprazole—Leukopenia—Topiramate—epilepsy syndrome	1.38e-05	0.000124	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.36e-05	0.000123	CcSEcCtD
Esomeprazole—Palpitations—Topiramate—epilepsy syndrome	1.36e-05	0.000123	CcSEcCtD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.36e-05	0.000542	CbGpPWpGaD
Esomeprazole—Insomnia—Gabapentin—epilepsy syndrome	1.35e-05	0.000122	CcSEcCtD
Esomeprazole—Nausea—Lamotrigine—epilepsy syndrome	1.35e-05	0.000122	CcSEcCtD
Esomeprazole—Cough—Topiramate—epilepsy syndrome	1.35e-05	0.000121	CcSEcCtD
Esomeprazole—Feeling abnormal—Pregabalin—epilepsy syndrome	1.35e-05	0.000121	CcSEcCtD
Esomeprazole—Paraesthesia—Gabapentin—epilepsy syndrome	1.34e-05	0.000121	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.34e-05	0.00012	CcSEcCtD
Esomeprazole—Dyspnoea—Gabapentin—epilepsy syndrome	1.34e-05	0.00012	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.33e-05	0.000531	CbGpPWpGaD
Esomeprazole—Hypertension—Topiramate—epilepsy syndrome	1.33e-05	0.00012	CcSEcCtD
Esomeprazole—Somnolence—Gabapentin—epilepsy syndrome	1.33e-05	0.00012	CcSEcCtD
Esomeprazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.33e-05	0.00012	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.33e-05	0.000528	CbGpPWpGaD
Esomeprazole—Dyspepsia—Gabapentin—epilepsy syndrome	1.32e-05	0.000119	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.32e-05	0.000524	CbGpPWpGaD
Esomeprazole—Myalgia—Topiramate—epilepsy syndrome	1.31e-05	0.000118	CcSEcCtD
Esomeprazole—Arthralgia—Topiramate—epilepsy syndrome	1.31e-05	0.000118	CcSEcCtD
Esomeprazole—Chest pain—Topiramate—epilepsy syndrome	1.31e-05	0.000118	CcSEcCtD
Esomeprazole—Anxiety—Topiramate—epilepsy syndrome	1.31e-05	0.000118	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.31e-05	0.00052	CbGpPWpGaD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.31e-05	0.000118	CcSEcCtD
Esomeprazole—Decreased appetite—Gabapentin—epilepsy syndrome	1.3e-05	0.000117	CcSEcCtD
Esomeprazole—Discomfort—Topiramate—epilepsy syndrome	1.3e-05	0.000117	CcSEcCtD
Esomeprazole—Urticaria—Pregabalin—epilepsy syndrome	1.3e-05	0.000117	CcSEcCtD
Esomeprazole—Asthenia—Valproic Acid—epilepsy syndrome	1.3e-05	0.000117	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.29e-05	0.000116	CcSEcCtD
Esomeprazole—Fatigue—Gabapentin—epilepsy syndrome	1.29e-05	0.000116	CcSEcCtD
Esomeprazole—Abdominal pain—Pregabalin—epilepsy syndrome	1.29e-05	0.000116	CcSEcCtD
Esomeprazole—Body temperature increased—Pregabalin—epilepsy syndrome	1.29e-05	0.000116	CcSEcCtD
Esomeprazole—Dry mouth—Topiramate—epilepsy syndrome	1.29e-05	0.000116	CcSEcCtD
Esomeprazole—Pain—Gabapentin—epilepsy syndrome	1.28e-05	0.000115	CcSEcCtD
Esomeprazole—Constipation—Gabapentin—epilepsy syndrome	1.28e-05	0.000115	CcSEcCtD
Esomeprazole—Pruritus—Valproic Acid—epilepsy syndrome	1.28e-05	0.000115	CcSEcCtD
Esomeprazole—Confusional state—Topiramate—epilepsy syndrome	1.27e-05	0.000114	CcSEcCtD
Esomeprazole—Infection—Topiramate—epilepsy syndrome	1.25e-05	0.000113	CcSEcCtD
Esomeprazole—Shock—Topiramate—epilepsy syndrome	1.24e-05	0.000112	CcSEcCtD
Esomeprazole—Diarrhoea—Valproic Acid—epilepsy syndrome	1.24e-05	0.000111	CcSEcCtD
Esomeprazole—Nervous system disorder—Topiramate—epilepsy syndrome	1.24e-05	0.000111	CcSEcCtD
Esomeprazole—Feeling abnormal—Gabapentin—epilepsy syndrome	1.23e-05	0.000111	CcSEcCtD
Esomeprazole—Thrombocytopenia—Topiramate—epilepsy syndrome	1.23e-05	0.000111	CcSEcCtD
Esomeprazole—Tachycardia—Topiramate—epilepsy syndrome	1.23e-05	0.000111	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.22e-05	0.00011	CcSEcCtD
Esomeprazole—Skin disorder—Topiramate—epilepsy syndrome	1.22e-05	0.00011	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.22e-05	0.000486	CbGpPWpGaD
Esomeprazole—Hyperhidrosis—Topiramate—epilepsy syndrome	1.22e-05	0.00011	CcSEcCtD
Esomeprazole—Hypersensitivity—Pregabalin—epilepsy syndrome	1.2e-05	0.000108	CcSEcCtD
Esomeprazole—Anorexia—Topiramate—epilepsy syndrome	1.2e-05	0.000108	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.2e-05	0.000476	CbGpPWpGaD
Esomeprazole—Dizziness—Valproic Acid—epilepsy syndrome	1.19e-05	0.000108	CcSEcCtD
Esomeprazole—Urticaria—Gabapentin—epilepsy syndrome	1.19e-05	0.000107	CcSEcCtD
Esomeprazole—Abdominal pain—Gabapentin—epilepsy syndrome	1.18e-05	0.000107	CcSEcCtD
Esomeprazole—Body temperature increased—Gabapentin—epilepsy syndrome	1.18e-05	0.000107	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.18e-05	0.00047	CbGpPWpGaD
Esomeprazole—Asthenia—Pregabalin—epilepsy syndrome	1.17e-05	0.000106	CcSEcCtD
Esomeprazole—Pruritus—Pregabalin—epilepsy syndrome	1.16e-05	0.000104	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—PDXK—epilepsy syndrome	1.15e-05	0.000458	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CERS1—epilepsy syndrome	1.15e-05	0.000458	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	1.15e-05	0.000458	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	1.15e-05	0.000458	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADK—epilepsy syndrome	1.15e-05	0.000458	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FAR1—epilepsy syndrome	1.15e-05	0.000458	CbGpPWpGaD
Esomeprazole—Vomiting—Valproic Acid—epilepsy syndrome	1.15e-05	0.000103	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.15e-05	0.000103	CcSEcCtD
Esomeprazole—Insomnia—Topiramate—epilepsy syndrome	1.14e-05	0.000103	CcSEcCtD
Esomeprazole—Rash—Valproic Acid—epilepsy syndrome	1.14e-05	0.000103	CcSEcCtD
Esomeprazole—Dermatitis—Valproic Acid—epilepsy syndrome	1.14e-05	0.000102	CcSEcCtD
Esomeprazole—Headache—Valproic Acid—epilepsy syndrome	1.13e-05	0.000102	CcSEcCtD
Esomeprazole—Paraesthesia—Topiramate—epilepsy syndrome	1.13e-05	0.000102	CcSEcCtD
Esomeprazole—Dyspnoea—Topiramate—epilepsy syndrome	1.12e-05	0.000101	CcSEcCtD
Esomeprazole—Somnolence—Topiramate—epilepsy syndrome	1.12e-05	0.000101	CcSEcCtD
Esomeprazole—Diarrhoea—Pregabalin—epilepsy syndrome	1.12e-05	0.000101	CcSEcCtD
Esomeprazole—Dyspepsia—Topiramate—epilepsy syndrome	1.11e-05	9.99e-05	CcSEcCtD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.1e-05	0.000439	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Gabapentin—epilepsy syndrome	1.1e-05	9.94e-05	CcSEcCtD
Esomeprazole—Decreased appetite—Topiramate—epilepsy syndrome	1.1e-05	9.86e-05	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.09e-05	9.8e-05	CcSEcCtD
Esomeprazole—Fatigue—Topiramate—epilepsy syndrome	1.09e-05	9.78e-05	CcSEcCtD
Esomeprazole—Dizziness—Pregabalin—epilepsy syndrome	1.08e-05	9.73e-05	CcSEcCtD
Esomeprazole—Constipation—Topiramate—epilepsy syndrome	1.08e-05	9.7e-05	CcSEcCtD
Esomeprazole—Pain—Topiramate—epilepsy syndrome	1.08e-05	9.7e-05	CcSEcCtD
Esomeprazole—Asthenia—Gabapentin—epilepsy syndrome	1.07e-05	9.68e-05	CcSEcCtD
Esomeprazole—Nausea—Valproic Acid—epilepsy syndrome	1.07e-05	9.66e-05	CcSEcCtD
Esomeprazole—Pruritus—Gabapentin—epilepsy syndrome	1.06e-05	9.54e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—GAMT—epilepsy syndrome	1.05e-05	0.000419	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PNPO—epilepsy syndrome	1.05e-05	0.000419	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	1.05e-05	0.000419	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	1.05e-05	0.000419	CbGpPWpGaD
Esomeprazole—Vomiting—Pregabalin—epilepsy syndrome	1.04e-05	9.35e-05	CcSEcCtD
Esomeprazole—Feeling abnormal—Topiramate—epilepsy syndrome	1.04e-05	9.35e-05	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.03e-05	9.28e-05	CcSEcCtD
Esomeprazole—Rash—Pregabalin—epilepsy syndrome	1.03e-05	9.27e-05	CcSEcCtD
Esomeprazole—Dermatitis—Pregabalin—epilepsy syndrome	1.03e-05	9.27e-05	CcSEcCtD
Esomeprazole—Diarrhoea—Gabapentin—epilepsy syndrome	1.02e-05	9.23e-05	CcSEcCtD
Esomeprazole—Headache—Pregabalin—epilepsy syndrome	1.02e-05	9.21e-05	CcSEcCtD
Esomeprazole—Urticaria—Topiramate—epilepsy syndrome	1e-05	9.01e-05	CcSEcCtD
Esomeprazole—Body temperature increased—Topiramate—epilepsy syndrome	9.96e-06	8.97e-05	CcSEcCtD
Esomeprazole—Abdominal pain—Topiramate—epilepsy syndrome	9.96e-06	8.97e-05	CcSEcCtD
Esomeprazole—Dizziness—Gabapentin—epilepsy syndrome	9.9e-06	8.92e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CA4—epilepsy syndrome	9.78e-06	0.000389	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—QDPR—epilepsy syndrome	9.78e-06	0.000389	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	9.75e-06	0.000388	CbGpPWpGaD
Esomeprazole—Nausea—Pregabalin—epilepsy syndrome	9.7e-06	8.74e-05	CcSEcCtD
Esomeprazole—Vomiting—Gabapentin—epilepsy syndrome	9.52e-06	8.58e-05	CcSEcCtD
Esomeprazole—Rash—Gabapentin—epilepsy syndrome	9.44e-06	8.5e-05	CcSEcCtD
Esomeprazole—Dermatitis—Gabapentin—epilepsy syndrome	9.43e-06	8.5e-05	CcSEcCtD
Esomeprazole—Headache—Gabapentin—epilepsy syndrome	9.38e-06	8.45e-05	CcSEcCtD
Esomeprazole—Hypersensitivity—Topiramate—epilepsy syndrome	9.28e-06	8.36e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—COX3—epilepsy syndrome	9.2e-06	0.000366	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CA13—epilepsy syndrome	9.13e-06	0.000363	CbGpPWpGaD
Esomeprazole—Asthenia—Topiramate—epilepsy syndrome	9.04e-06	8.14e-05	CcSEcCtD
Esomeprazole—Pruritus—Topiramate—epilepsy syndrome	8.91e-06	8.03e-05	CcSEcCtD
Esomeprazole—Nausea—Gabapentin—epilepsy syndrome	8.89e-06	8.01e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	8.72e-06	0.000347	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PFKL—epilepsy syndrome	8.72e-06	0.000347	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	8.72e-06	0.000347	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	8.72e-06	0.000347	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	8.72e-06	0.000347	CbGpPWpGaD
Esomeprazole—Diarrhoea—Topiramate—epilepsy syndrome	8.62e-06	7.76e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.47e-06	0.000337	CbGpPWpGaD
Esomeprazole—Dizziness—Topiramate—epilepsy syndrome	8.33e-06	7.5e-05	CcSEcCtD
Esomeprazole—Vomiting—Topiramate—epilepsy syndrome	8.01e-06	7.21e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—ATIC—epilepsy syndrome	7.98e-06	0.000317	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UPB1—epilepsy syndrome	7.98e-06	0.000317	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NEU1—epilepsy syndrome	7.98e-06	0.000317	CbGpPWpGaD
Esomeprazole—Rash—Topiramate—epilepsy syndrome	7.94e-06	7.15e-05	CcSEcCtD
Esomeprazole—Dermatitis—Topiramate—epilepsy syndrome	7.94e-06	7.15e-05	CcSEcCtD
Esomeprazole—Headache—Topiramate—epilepsy syndrome	7.89e-06	7.11e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	7.68e-06	0.000305	CbGpPWpGaD
Esomeprazole—Nausea—Topiramate—epilepsy syndrome	7.48e-06	6.74e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—GBE1—epilepsy syndrome	7.41e-06	0.000295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	7.41e-06	0.000295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.25e-06	0.000288	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	6.97e-06	0.000277	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	6.92e-06	0.000275	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FAR1—epilepsy syndrome	6.92e-06	0.000275	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADK—epilepsy syndrome	6.92e-06	0.000275	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CERS1—epilepsy syndrome	6.92e-06	0.000275	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	6.92e-06	0.000275	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PDXK—epilepsy syndrome	6.92e-06	0.000275	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	6.78e-06	0.00027	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NT5E—epilepsy syndrome	6.61e-06	0.000263	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALAD—epilepsy syndrome	6.61e-06	0.000263	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	6.33e-06	0.000252	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	6.33e-06	0.000252	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	6.33e-06	0.000252	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	6.33e-06	0.000252	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	6.3e-06	0.000251	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	6.3e-06	0.000251	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	6.17e-06	0.000245	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADSL—epilepsy syndrome	6.04e-06	0.00024	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GLUL—epilepsy syndrome	5.93e-06	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.88e-06	0.000234	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.88e-06	0.000234	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.87e-06	0.000233	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	5.82e-06	0.000231	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.53e-06	0.00022	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	5.44e-06	0.000216	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.28e-06	0.00021	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.24e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.24e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.24e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.24e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.24e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.07e-06	0.000202	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.8e-06	0.000191	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.8e-06	0.000191	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.8e-06	0.000191	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.78e-06	0.00019	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.78e-06	0.00019	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.62e-06	0.000184	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.46e-06	0.000177	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.46e-06	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.45e-06	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.36e-06	0.000173	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.19e-06	0.000167	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.08e-06	0.000162	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.97e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.97e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.9e-06	0.000155	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.79e-06	0.000151	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.79e-06	0.000151	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.77e-06	0.00015	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.75e-06	0.000149	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.71e-06	0.000148	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.63e-06	0.000145	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.56e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.5e-06	0.000139	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.41e-06	0.000136	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.4e-06	0.000135	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.27e-06	0.00013	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.24e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.23e-06	0.000128	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.18e-06	0.000126	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.08e-06	0.000122	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.05e-06	0.000121	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TH—epilepsy syndrome	3.03e-06	0.000121	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.99e-06	0.000119	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.87e-06	0.000114	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.87e-06	0.000114	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.53e-06	0.000101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.5e-06	9.94e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.43e-06	9.67e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.34e-06	9.31e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.28e-06	9.08e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.27e-06	9.02e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.26e-06	8.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.05e-06	8.14e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.98e-06	7.88e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.95e-06	7.75e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.94e-06	7.72e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.94e-06	7.72e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.85e-06	7.36e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.83e-06	7.28e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TH—epilepsy syndrome	1.82e-06	7.26e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.67e-06	6.63e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	6.06e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.52e-06	6.05e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.5e-06	5.98e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	5.81e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.36e-06	5.4e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.33e-06	5.29e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.19e-06	4.74e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.17e-06	4.64e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	1e-06	3.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.14e-07	3.64e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8e-07	3.18e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—epilepsy syndrome	6.69e-07	2.66e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.02e-07	1.6e-05	CbGpPWpGaD
